Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fluxtrol is a global leader in magnetic flux control and induction heating technology, specializing in the development of soft magnetic composites (SMC) and high-precision induction systems. While the company serves diverse industrial sectors, it has a significant footprint in the life sciences through its specialized biomedical applications, including magnetic nanoparticle hyperthermia for cancer treatment and nanowarming for organ preservation. Fluxtrol's technology platform enables the precise control of alternating magnetic fields, which is critical for emerging therapies that require localized heating of tissues or the rapid rewarming of cryopreserved biological materials. Through its spin-off, AMF Life Systems, the company provides advanced equipment and engineering services to researchers and clinical developers in the biotechnology and healthcare industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fluxtrol.